Greatview, a China-based aseptic-packaging manufacturer listed in Hong Kong in 2010, became embroiled in an accounting and governance dispute over the restructuring of its international business. Investigators questioned its continued consolidation, transaction calculations and undisclosed arrangements involving former management. The delayed FY24 accounts received an audit disclaimer, while FY25 remained qualified. Shares remain suspended and Greatview has sought a review of a delisting decision. An A&G Screen of the 1H24 accounts rates the company Medium Risk, triggering Large/Rising Net Receivables. [3] [10] [13] [14] [16] [18]

The information on this page has been compiled from publicly available sources. GMT Research Limited has not verified the information and does not warrant its accuracy. Any claims made or views expressed are not necessarily those of GMT Research Limited.